IFNA1 and COVID-19: Insufficient or delayed IFN response, later than the peak of clinical symptoms and viral replication, is a prominent feature of the acute phase of severe COVID-19.5,51,52 Additionally, the IFN response decreased over time during the inflammation resolution.